Log In

 
Company : Sahajanand Medical Technologies Pvt. Ltd. (SMT) 
Thursday, September 29, 2016 4:00PM IST (10:30AM GMT)
 
SMT Expands Global Footprint
Opens new R&D facility in Ireland
 
Mumbai, Maharashtra, India

Sahajanand Medical Technologies Pvt. Ltd. (SMT), India’s largest manufacturer of cardiovascular medical stents today announced the opening of its new Research & Development Centre in Galway City, Ireland. SMT aims to attract global talent through this new facility in Ireland to diversify its product portfolio. The company has significant investment plans to develop this R&D Centre.

The core functions of SMT Ireland Centre would be R&D and logistics. The key on-going research projects at the facility are developing next generation of Stent and Advanced Balloon Catheter technology. The centre will have detailed and advanced research on developing next generation stent. It will be working on an advanced balloon catheter and stent bifurcation application which will be a great help in complex cases. The centre will also be flexible from logistics point of view as it will be able to track and deliver the stents and other products in various parts of the world.

The Ireland centre also plans to develop new range of peripheral products along with guidewires and other coronary accessories. The R&D leadership team is in place now and more researchers are expected to join the team in the coming weeks.

Commenting on the launch, Mr. Ganesh Sabat, CEO of SMT, said, “We were pioneers amongst Indian medical device companies and have seen tremendous value in investing in research & development (R&D). Our early investments in R&D, beginning one and half decades ago, enabled us to make technology our key differentiator and develop a robust coronary stent for the world. Our core strength lies in our ability to excel in developing technologically complex products through focused teams.”

The launch of the centre today was attended by Mr. Sean Kyne, Minister of State, and Mr. Noel Larkin, Mayor of Galway City. The launch was also attended by the SMT Head of Europe, Mr. Gaurav Goel and the SMT Vice President of International Sales & Marketing, Mr. Ilancheran Uthirapathi.

This is a major investment by SMT to remain ahead of the curve in adopting latest technologies through advanced research and compete with global competitors. Our aim is to continue to provide the most advanced technology to our consumers at competitive prices hence aligning with our vision of ‘pledge to save millions’. With this centre, we hope to tap into the global talent pool and explore the possible adaptation into the Indian market and strengthen India as a medical device manufacturing hub. This will provide a big fillip to support our Prime Minister’s dream of Make in India in the medical device industry.”

About Sahajanand Medical Technologies

Established in the year 1998, SMT became the first indigenous player in India to successfully launch coronary stent. SMT is also the first company to get CE approval for DES with Biodegradable Polymers in the world. It is India's largest stent manufacturing company and sells its product in more than 60 countries across the world. The products are manufactured in a state of the art manufacturing facility located in Surat. The Company is ISO 9001 and ISO 13485 certified & it has also obtained CE certification for all of its products. www.smtpl.com

 
For News Release background on Sahajanand Medical Technologies Pvt. Ltd. (SMT) click here
 
Media Contact Details
Sarah Rajan, Madison Public Relations, +91-9920495218
Christina Moniz, Madison Public Relations, +91-9819037059
 
 
Submit your press release
More News from Sahajanand Medical Technologies Pvt. Ltd. (SMT)

12/01/2018 5:45PM

SMT (Sahajanand Medical Technologies) Raises INR 230 Crores of Equity Capital in a Round Led by a Fund Managed by Morgan Stanley Private Equity Asia

SMT, the leading manufacturer of cardiac stents in India, is pleased to announce that it has successfully raised equity to the tune of Rs. 230 crore in a funding round led by Morgan Stanley Private Equity Asia. Existing ...

Similar News

24/02/2018 10:40PM

Mother Who Lost Infant Son to Medical Error to Join Panel at World Patient Safety, Science & Technology Summit

New mother Deahna Visscher was feeling hopeful. Although her son Grant had been born with a heart defect, he was doing very well after surgery. Just 11-days old, doctors felt he could soon leave the hospital. But that ...

No Image

24/02/2018 11:15AM

Pidilite Unveils its New Dr. Fixit Campaign

Dr. Fixit, from the house of Pidilite, today unveiled its new TVC campaign featuring legendary actor Amitabh Bachchan.